Advertisement
Screener

TFF PHARMACEUTICALS, INC. Form DEF 14A: Definitive proxy statement

TFF PHARMACEUTICALS, INC. Form DEF 14A: Definitive proxy statement

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2024-12-23: Form DEF 14A; Period of report 2025-01-28; Description PROXY STATEMENT; Document ea022445802-def14a_tff.htm.
  • 2024-04-22: Form DEF 14A; Period of report 2024-06-04; Description PROXY STATEMENT; Document ea0204242-01.htm.
  • 2023-10-04: Form DEF 14A; Period of report 2023-11-21; Description PROXY STATEMENT; Document def14a1023_tffpharma.htm.
  • 2022-12-27: Form DEF 14A; Period of report 2023-02-08; Description DEFINITIVE PROXY STATEMENT; Document ea170837-def14a_tffpharma.htm.
FiledFormPeriod of reportDescriptionDocument
2024-12-23DEF 14A2025-01-28PROXY STATEMENTea022445802-def14a_tff.htm
2024-04-22DEF 14A2024-06-04PROXY STATEMENTea0204242-01.htm
2023-10-04DEF 14A2023-11-21PROXY STATEMENTdef14a1023_tffpharma.htm
2022-12-27DEF 14A2023-02-08DEFINITIVE PROXY STATEMENTea170837-def14a_tffpharma.htm
2022-09-21DEF 14A2022-11-07DEFINITIVE PROXY STATEMENTea166031-def14a_tffpharma.htm
2021-09-23DEF 14A2021-11-04DEFINITIVE PROXY STATEMENTdef14a0921_tffpharma.htm
2020-08-28DEF 14A2020-09-30DEFINITIVE PROXY STATEMENTea126131-def14a_tffpharma.htm